Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

Ítems similars

• Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
  per: McLaurin, Eugene B., et al.
  Publicat: (2014)
• Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management
  per: Ackerman, Stacey, et al.
  Publicat: (2016)
• A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model
  per: Ackerman, Stacey, et al.
  Publicat: (2013)
• Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
  per: Chigbu, DeGaulle I, et al.
  Publicat: (2015)
• Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
  per: Wingard, Jeremy B, et al.
  Publicat: (2011)